
Lilly’s Zepbound Cut Risk of Diabetes by 94% in Obese People
Bloomberg Businessweek
00:00
Exploring Weight Loss Drugs and Their Long-Term Health Implications
This chapter explores the impacts of weight loss medications on health, focusing on type 2 diabetes and obesity-related conditions. It considers recent findings on their effectiveness, the implications of long-term use, and the interplay of economic factors and treatment combinations for optimal patient outcomes.
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.